Cash, cash equivalents and marketable securities were $352.4 million as of December 31, 2024, compared to $75.2 million as of December 31, 2023. Based on current operating plans, Metsera (MTSR) estimates its existing cash and cash equivalents of $352.4 at year end, together with the net proceeds from the IPO, will be sufficient to fund our projected operating expenses, working capital and capital expenditure needs into 2027.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MTSR:
- Metsera, Inc. Approves 2024 Executive Cash Bonuses
- Metsera initiated with an Outperform at Evercore ISI
- Metsera, Inc.: Buy Rating Affirmed Due to Innovative Obesity Market Approach and Strong Growth Catalysts
- Metsera initiated with a Buy at BofA
- Metsera, Inc.: A Promising Buy in the Obesity Market with Potential for Significant Returns